Latest in News & Research
Actinic Keratosis Diagnosed in Almost One-Third of Older Adults
Authors say increased use of topical fluorouracil may be warranted
Treatment Needs Often Unmet for Generalized Pustular Psoriasis
Patients with flares more likely to have inpatient, emergency department visits
Causal Link Suggested for Psoriasis, Cardiovascular Disease
Increased risks noted for heart failure, atrial fibrillation, myocardial infarction, valvular heart disease, large artery stroke
What Is the Long-Term Drug Survival of Dupilumab in Patients With Eczema?
Dupilumab demonstrates sufficient drug survival up to three years for treatment of atopic dermatitis
Hypericin Photodynamic Therapy Effective for Early-Stage MF/CTCL
Hypericin PDT more effective than placebo after six weeks of treatment; index lesion response rate increased with progressive cycles of treatment
FDA Warns Amazon, Other Vendors About Sale of Skin Tag Removal Products
No over-the-counter medications have FDA approval for the removal of moles and skin tags
Atopic Eczema Tied to Higher Risk for Dementia in Older Adults
Dose-response relationship seen, with greater risk with more severe eczema
Dermatologist Visits Shorter for Asian Psoriasis Patients
Asian patients have visits of shorter mean duration compared with White patients, non-Asian patients as a single group
Two Years of Tralokinumab Safe, Efficacious for Atopic Dermatitis
75 percent improvement in Eczema Area and Severity Index was 82.5 percent with two years of tralokinumab
Did COVID-19 Diagnostic Delay Affect Melanoma, cSCC Characteristics?
No significant differences seen in mean primary melanoma Breslow thickness for prepandemic era, subsequent periods
Banana Boat Sunscreen Recalled Due to Benzene
Company says it has not received any reports of adverse events
Characteristics of Photoaggravated Atopic Dermatitis Described
Response rates for deucravacitinib significantly higher versus placebo or apremilast for PASI 75, sPGA 0/1
Is Deucravacitinib Effective, Well Tolerated for Plaque Psoriasis?
Response rates for deucravacitinib significantly higher versus placebo or apremilast for PASI 75, sPGA 0/1
AI and Dermatologists Similarly Judge Melanoma Thickness
Readers most accurately discriminated between thin (≤1.0 mm) and thick melanomas (>1.0 mm)
Manifestations of Monkeypox Described in Case Series
95 percent of 528 cases presented with rash; 73 and 41 percent had anogenital and mucosal lesions, respectively
T-Cell-Rich Lymphoid Infiltrates ID'd After Pfizer COVID-19 Shot
Three types of infiltrates revealed on histologic examination including cutaneous T-cell lymphoid hyperplasia
Does Margin Status Impact Recurrence in Scalp cSCC?
No association seen with risk for local recurrence, but five-year disease-specific mortality lower for patients with clear margins versus close/involved margins
FDA Approves First Topical Treatment for Vitiligo
Opzelura can be used twice daily in patients ages 12 years and older
Smoking Is Causally Associated With Psoriasis Risk
Causal effect found of smoking initiation, cigarettes per day, lifetime smoking on psoriasis; no causal link seen for alcohol consumption
Urgent Health Care Use Up for Adults With Concomitant Eczema, Asthma
Those with concomitant atopic dermatitis, asthma had increased risk for hospitalizations and fewer visits in outpatient clinics
Berdazimer Gel Efficacious, Safe for Molluscum Contagiosum
Odds of complete clearance of MC lesions increased for patients receiving berdazimer gel 10.3 percent versus vehicle for 12 weeks
Do Melanoma Surgical Delays Impact Mortality Outcomes?
Adjusted survival curves from the multivariable model for effectiveness showed higher drug survival for guselkumab
Tapinarof Effective for Longer-Term Treatment of Plaque Psoriasis
Complete disease clearance observed in 41 percent of patients with tapinarof cream 1 percent used once daily
24 of 1274